EUVIMEDEUVIMED entdecken
Kommentar

In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo

Eric R Bates

Annals of Internal Medicine · 2024

DOI: 10.7326/j24-0026 ↗

Kurz gefasst

Kommentar in der Zeitschrift Annals of Internal Medicine, 2024. Verfasst von Eric R Bates. Beteiligte Einrichtung: University of Michigan, Ann Arbor, Michigan, USA (E.R.B.). Hauptthemen laut MEDLINE: Colchicine, Diabetes Mellitus, Type 2, Myocardial Infarction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SOURCE CITATION: Roubille F, Bouabdallaoui N, Kouz S, et al. Low-dose colchicine in patients with type 2 diabetes and recent myocardial infarction in the COLchicine Cardiovascular Outcomes Trial (COLCOT). Diabetes Care. 2024;47:467-470. 38181203.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColchicineDiabetes Mellitus, Type 2Myocardial InfarctionAgedFemaleHumansMaleMiddle AgedRandomized Controlled Trials as Topic

Substanzen

Colchicine

Autor:innen und Institutionen

  • University of Michigan, Ann Arbor, Michigan, USA (E.R.B.).

Zitieren

APA

Bates, E. R. (2024). In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo. Annals of Internal Medicine. https://doi.org/10.7326/j24-0026

Vancouver

Bates ER. In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo. Annals of Internal Medicine. 2024. doi:10.7326/j24-0026

BibTeX
@article{Bates2024,
  author = {Bates, Eric R},
  title = {In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo},
  journal = {Annals of Internal Medicine},
  year = {2024},
  doi = {10.7326/j24-0026}
}
Kostenlos starten →